A. Barnadas

546 total citations
27 papers, 419 citations indexed

About

A. Barnadas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Barnadas has authored 27 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in A. Barnadas's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (6 papers) and Genetic factors in colorectal cancer (4 papers). A. Barnadas is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (6 papers) and Genetic factors in colorectal cancer (4 papers). A. Barnadas collaborates with scholars based in Spain, United States and Italy. A. Barnadas's co-authors include Gloria Peiró, Alberto Gallardo, Daniel Escuín, Ariadna Tibau, Enrique Lerma, Fernando Ortiz-Martínez, Encarna Adrover, Daniel Giner, Laura Sánchez-Tejada and B. Ojeda and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and British Journal of Cancer.

In The Last Decade

A. Barnadas

26 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Barnadas Spain 10 244 179 88 84 83 27 419
Greg Friberg United States 10 189 0.8× 259 1.4× 116 1.3× 50 0.6× 95 1.1× 15 488
Saif Zaman United States 13 351 1.4× 175 1.0× 47 0.5× 65 0.8× 61 0.7× 38 518
Jason L. Rowand United States 5 125 0.5× 251 1.4× 80 0.9× 83 1.0× 62 0.7× 6 369
Jean-Yves Leroy Belgium 6 396 1.6× 223 1.2× 49 0.6× 104 1.2× 158 1.9× 11 465
U Vogt Germany 13 320 1.3× 293 1.6× 108 1.2× 110 1.3× 114 1.4× 32 580
Gou Watanabe Japan 11 306 1.3× 201 1.1× 67 0.8× 102 1.2× 123 1.5× 25 596
Christine Khoo Australia 12 234 1.0× 222 1.2× 145 1.6× 44 0.5× 148 1.8× 21 552
Manuela Gili Spain 4 190 0.8× 328 1.8× 106 1.2× 53 0.6× 54 0.7× 6 464
Niharika B. Mettu United States 11 374 1.5× 138 0.8× 87 1.0× 48 0.6× 77 0.9× 40 507
Fernando Ortiz-Martínez Spain 9 220 0.9× 221 1.2× 77 0.9× 78 0.9× 120 1.4× 12 419

Countries citing papers authored by A. Barnadas

Since Specialization
Citations

This map shows the geographic impact of A. Barnadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Barnadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Barnadas more than expected).

Fields of papers citing papers by A. Barnadas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Barnadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Barnadas. The network helps show where A. Barnadas may publish in the future.

Co-authorship network of co-authors of A. Barnadas

This figure shows the co-authorship network connecting the top 25 collaborators of A. Barnadas. A scholar is included among the top collaborators of A. Barnadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Barnadas. A. Barnadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López–Pousa, Antonio, Miquel Quer, Mercedes Camacho, et al.. (2016). Risk of distant metastases in head and neck carcinoma patients and myeloperoxidase (MPO) expression.. Journal of Clinical Oncology. 34(15_suppl). 6067–6067. 1 indexed citations
2.
Anguera, Geòrgia, Ariadna Tibau, Fernando Andrés‐Pretel, et al.. (2015). 1215 Role of cooperative groups and funding source in clinical studies that support approved therapy for breast cancer. European Journal of Cancer. 51. S176–S177. 1 indexed citations
3.
Paré, Laia, Ana Sebio, Juliana Salazar, et al.. (2015). Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy. The Pharmacogenomics Journal. 15(5). 397–404. 12 indexed citations
4.
Sebio, Ana, Juliana Salazar, David Páez, et al.. (2014). EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer. The Pharmacogenomics Journal. 15(1). 77–83. 13 indexed citations
5.
Peiró, Gloria, Fernando Ortiz-Martínez, Alberto Gallardo, et al.. (2014). Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. British Journal of Cancer. 111(4). 689–695. 72 indexed citations
6.
7.
Martín, Miguel, Aňa Lluch, Amparo Ruı́z, et al.. (2012). Randomized phase III study of adjuvant chemotherapy for high-risk, node-negative breast cancer (BC) comparing FAC with FAC followed by weekly paclitaxel: First efficacy analysis of the GEICAM/2003-02 trial.. Journal of Clinical Oncology. 30(15_suppl). 1001–1001. 1 indexed citations
8.
Pavón, Miguel Ángel, Matilde Parreño, Marta Tellez Gabriel, et al.. (2012). Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma. Carcinogenesis. 33(9). 1707–1716. 26 indexed citations
9.
Gallardo, Alberto, Enrique Lerma, Daniel Escuín, et al.. (2012). Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. British Journal of Cancer. 106(8). 1367–1373. 188 indexed citations
10.
Stradella, Agostina, David Páez, Eduardo M. Targarona, et al.. (2012). Prognostic Value of BRAF and KRAS Mutations in Colorectal Cancer Patients. Annals of Oncology. 23. ix216–ix216.
11.
Gallego, Rosa, Marta Martín-Richard, Carles Pericay, et al.. (2012). Phase II study of oxaliplatin and sorafenib in advanced gastric cancer after failure of cisplatin-fluoropyrimidine-based (PF) treatment.. Journal of Clinical Oncology. 30(15_suppl). 4079–4079. 4 indexed citations
12.
Lasa, Adriana, Teresa Ramón y Cajal, Gemma Llort, et al.. (2010). Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation. Breast Cancer Research and Treatment. 123(3). 901–905. 11 indexed citations
13.
Pallarés, Cinta, Jaume Capdevila, Alfredo Paredes, et al.. (2007). Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial. Lung Cancer. 58(2). 238–245. 10 indexed citations
14.
Paré, Laia, E. Marcuello, Albert Altés, et al.. (2007). Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin?. The Pharmacogenomics Journal. 8(5). 315–320. 9 indexed citations
15.
Ojeda, B., Vicenç Artigas, Ignasi Gich, et al.. (2006). Stratification of the normal range of CA125 after chemotherapy as a predictive factor in carcinoma of the ovary. Journal of Clinical Oncology. 24(18_suppl). 5059–5059. 2 indexed citations
16.
Puértolas, Teresa, et al.. (2004). Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes. Journal of Clinical Oncology. 22(14_suppl). 751–751. 4 indexed citations
17.
Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2004). Risk-adapted management of stage I seminoma: The second Spanish Germ Cell Cancer Group (GG) study. Journal of Clinical Oncology. 22(14_suppl). 4518–4518. 5 indexed citations
18.
Muro, Xavier García del, Pablo Maroto, A. Barnadas, et al.. (2003). 884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience. European Journal of Cancer Supplements. 1(5). S266–S266. 1 indexed citations
19.
Ribelles, Nuria, et al.. (1997). Validation of breast cancer prognostic models. Oncology Reports. 4(2). 419–23. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greg Friberg Breakdown of academic impact, for papers by Saif Zaman Breakdown of academic impact, for papers by Jason L. Rowand Breakdown of academic impact, for papers by Jean-Yves Leroy Breakdown of academic impact, for papers by U Vogt Breakdown of academic impact, for papers by Gou Watanabe Breakdown of academic impact, for papers by Christine Khoo Breakdown of academic impact, for papers by Manuela Gili Breakdown of academic impact, for papers by Niharika B. Mettu Breakdown of academic impact, for papers by Fernando Ortiz-Martínez
Rankless by CCL
2026